News and Trends 8 Aug 2022
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
…jointly work to research, develop, and commercialize novel monospecific antibody candidates for various cancer indications. Since 2015, the companies have been working on the joint development of bispecific cancer antibodies…